119 related articles for article (PubMed ID: 2054268)
21. [Antisecretory effect of the H2-histamine receptor antagonist ranitidine in water-soluble tablets and film-coated tablets. Results of a randomized, placebo-controlled crossover study in humans].
Witzel L; Röhmel J
Arzneimittelforschung; 1990 Apr; 40(4):457-9. PubMed ID: 2192716
[TBL] [Abstract][Full Text] [Related]
22. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
23. Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers.
Kees MG; Steinke T; Moritz S; Rupprecht K; Paulus EM; Kees F; Bucher M; Faerber L
J Clin Pharmacol; 2012 Aug; 52(8):1265-72. PubMed ID: 21903891
[TBL] [Abstract][Full Text] [Related]
24. The anti-secretory effect and pharmacokinetics of omeprazole in chronic liver disease.
McKee RF; MacGilchrist AJ; Garden OJ; Forrest JA; Carter DC
Aliment Pharmacol Ther; 1988 Oct; 2(5):429-37. PubMed ID: 2979265
[TBL] [Abstract][Full Text] [Related]
25. Omeprazole--a new formulation.
Armstrong D
Can J Gastroenterol; 1997; 11(8):655-6. PubMed ID: 9459043
[No Abstract] [Full Text] [Related]
26. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Kakuda TN; Falcon RW
Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
[TBL] [Abstract][Full Text] [Related]
27. Influence of gastric acid secretion blockade and food intake on the bioavailability of a potassium diclofenac suspension in healthy male volunteers.
Poli A; Moreno RA; Ribeiro W; Dias HB; Moreno H; Muscara MN; De Nucci G
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):76-9. PubMed ID: 8929750
[TBL] [Abstract][Full Text] [Related]
28. Gastric emptying and absorption of acetylsalicylic acid administered as enteric-coated micro-granules.
Alpsten M; Bogentoft C; Ekenved G; Sölvell L
Eur J Clin Pharmacol; 1982; 22(1):57-61. PubMed ID: 7094976
[TBL] [Abstract][Full Text] [Related]
29. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms.
Bogentoft C; Carlsson I; Ekenved G; Magnusson A
Eur J Clin Pharmacol; 1978 Dec; 14(5):351-5. PubMed ID: 32046
[TBL] [Abstract][Full Text] [Related]
30. The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet.
Betlach CJ; Straughn AB; Meyer MC; Bialer M; Vashi VI; Liebermann P; González MA
Pharm Res; 1991 Dec; 8(12):1516-9. PubMed ID: 1808616
[TBL] [Abstract][Full Text] [Related]
31. Effect of omeprazole on gastric acid secretion and plasma gastrin.
Olbe L; Cederberg C; Lind T; Olausson M
J Gastroenterol Hepatol; 1989; 4 Suppl 2():19-25. PubMed ID: 2491358
[TBL] [Abstract][Full Text] [Related]
32. Effect of omeprazole on plasma zinc levels after oral zinc administration.
Ozutemiz AO; Aydin HH; Isler M; Celik HA; Batur Y
Indian J Gastroenterol; 2002; 21(6):216-8. PubMed ID: 12546170
[TBL] [Abstract][Full Text] [Related]
33. Effect of meal and antisecretory agents on the pharmacokinetics of danoprevir/ritonavir in healthy volunteers.
Morcos PN; Moreira SA; Navarro MT; Bech N; Quatkemeyer A; Smith PF; Brennan BJ
J Pharm Pharmacol; 2014 Jan; 66(1):23-31. PubMed ID: 24117531
[TBL] [Abstract][Full Text] [Related]
34. Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers.
Garg SK; Chugh Y; Tripathi SK; Kumar N; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):96-9. PubMed ID: 8458683
[TBL] [Abstract][Full Text] [Related]
35. A randomized crossover study investigating the influence of ranitidine or omeprazole on the pharmacokinetics of cephalexin monohydrate.
Madaras-Kelly K; Michas P; George M; May MP; Adejare A
J Clin Pharmacol; 2004 Dec; 44(12):1391-7. PubMed ID: 15545310
[TBL] [Abstract][Full Text] [Related]
36. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil.
Hughes GS; Heald DL; Barker KB; Patel RK; Spillers CR; Watts KC; Batts DH; Euler AR
Clin Pharmacol Ther; 1989 Dec; 46(6):674-85. PubMed ID: 2557183
[TBL] [Abstract][Full Text] [Related]
37. Gastric acid antisecretory effect of two different dosage forms of omeprazole during prolonged oral treatment in the gastric fistula dog.
Larsson H; Mattsson H; Carlsson E
Scand J Gastroenterol; 1988 Oct; 23(8):1013-9. PubMed ID: 3201125
[TBL] [Abstract][Full Text] [Related]
38. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
Kiilerich S; Rannem T; Elsborg L
Digestion; 1995; 56(1):25-30. PubMed ID: 7895928
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
40. Oral pharmacokinetics of omeprazole.
Howden CW; Meredith PA; Forrest JA; Reid JL
Eur J Clin Pharmacol; 1984; 26(5):641-3. PubMed ID: 6468483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
